Clinical Trial Update: Axi-cel in CNS Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 study of axicabtagene ciloleucel in CNS lymphoma is active but not recruiting, with Dana-Farber as sponsor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma
• Lymphoma

Drugs mentioned

• Axi-cel (axicabtagene ciloleucel)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Lymphoma, Lymphoma Cns | Phase 1 | Status: ACTIVE_NOT_RECRUITING